Literature DB >> 31805188

Leukocytosis and thrombosis in polycythemia vera: can clinical trials settle the debate?

Tiziano Barbui1, Alessandra Carobbio1, Alberto Ferrari1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31805188      PMCID： PMC6963256          DOI： 10.1182/bloodadvances.2019001159

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  5 in total

1.  Leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera: a systematic review and meta-analysis.

Authors:  Alessandra Carobbio; Alberto Ferrari; Arianna Masciulli; Arianna Ghirardi; Giovanni Barosi; Tiziano Barbui
Journal:  Blood Adv       Date:  2019-06-11

Review 2.  Registration in the international prospective register of systematic reviews (PROSPERO) of systematic review protocols was associated with increased review quality.

Authors:  Sofia Sideri; Spyridon N Papageorgiou; Theodore Eliades
Journal:  J Clin Epidemiol       Date:  2018-01-12       Impact factor: 6.437

3.  Response to meta-analysis of leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera.

Authors:  Lukas Ronner; John Mascarenhas; Erin L Moshier
Journal:  Blood Adv       Date:  2019-10-22

Review 4.  Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.

Authors:  D F Stroup; J A Berlin; S C Morton; I Olkin; G D Williamson; D Rennie; D Moher; B J Becker; T A Sipe; S B Thacker
Journal:  JAMA       Date:  2000-04-19       Impact factor: 56.272

5.  Addressing and proposing solutions for unmet clinical needs in the management of myeloproliferative neoplasm-associated thrombosis: A consensus-based position paper.

Authors:  Tiziano Barbui; Valerio De Stefano; Anna Falanga; Guido Finazzi; Ida Martinelli; Francesco Rodeghiero; Alessandro M Vannucchi; Giovanni Barosi
Journal:  Blood Cancer J       Date:  2019-08-08       Impact factor: 11.037
  5 in total
  2 in total

1.  Circulating Protein Disulfide Isomerase Is Associated with Increased Risk of Thrombosis in JAK2-Mutated Myeloproliferative Neoplasms.

Authors:  Anish V Sharda; Thomas Bogue; Alexandra Barr; Lourdes M Mendez; Robert Flaumenhaft; Jeffrey I Zwicker
Journal:  Clin Cancer Res       Date:  2021-08-16       Impact factor: 13.801

Review 2.  Polycythemia vera: historical oversights, diagnostic details, and therapeutic views.

Authors:  Ayalew Tefferi; Alessandro M Vannucchi; Tiziano Barbui
Journal:  Leukemia       Date:  2021-09-03       Impact factor: 11.528
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.